Ionpath logo — Enabling precision medicine through high-definition spatial...

Ionpath

Enabling precision medicine through high-definition spatial proteomics

Founded 2014 United States Menlo Park, United States 32 employees Corporate Round Total: $18.00M Biotechnology, Health Care

General Information

Company Name Ionpath
Founded Year 2014
Location United States Menlo Park, United States
Employees 32
Industries Biotechnology, Health Care
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with Ionpath. To contact Ionpath, visit ionpath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ionpath compare?

A PDF of Ionpath and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ionpath soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ionpath

Ionpath has developed advanced ion beam imaging technology to revolutionize cancer diagnosis, with the aim of contributing to the improvement of human health. This innovation enables the precise examination of tissue biopsies, surpassing the capabilities of light microscopy. By catering to various tissue states, including fresh, frozen, or FFPE, Ionpath's technology significantly enhances the capability of healthcare providers to diagnose cancer effectively. Established in 2014, Ionpath operates within the Biotechnology and Health Care industries. Their commitment to innovation and impact is evident from their recent Corporate Round investment on 11 May 2022, with Thermo Fisher Scientific being their investing partner. Overall, Ionpath's cutting-edge technology and strategic partnerships position the company as a promising player in the healthcare industry, with potential for significant impact and growth.

Business keywords: medical imaging, ion beam technology, cancer diagnosis, tissue analysis, biopsy technology, precision medicine, biomedical technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round Undisclosed 1
Thermo Fisher Scientific
11 May 2022
Series B $18.00M 9
Genoa Ventures, Norwich Ventures +7
24 Sep 2020
Series A Undisclosed -
20 Jan 2018
Seed Round Undisclosed -
01 Oct 2015

Ionpath Alternatives & Competitors

View All Alternatives
Ionpath vs
RareCyte, Inc.
RareCyte, Inc. United States

A one-stop resource for Spatial Biology and Liquid Biopsy solutions.

Venture round
65 employees
Biotechnology, Health Care
Ionpath vs
Navinci
Navinci Sweden

Illuminating function is spatial proteomics

Series A
31 employees
Biotechnology, Health Care
Ionpath vs
SageMedic Corp.
SageMedic Corp. Afghanistan

Never compromise to find your best treatment!

Series A
11 employees
Biotechnology, Health Care

FAQ About Ionpath

Enabling precision medicine through high-definition spatial proteomics
Ionpath was founded in 2014.
Ionpath is headquartered in Menlo Park, United States.
Ionpath operates in Biotechnology and Health Care. Its work centres on medical imaging, ion beam technology, cancer diagnosis and tissue analysis.
Ionpath has approximately 32 employees.
Ionpath has completed 4 funding rounds, raising a total of $18.00M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Ionpath include RareCyte, Inc., Navinci, SageMedic Corp., Exact Imaging, Insight Medbotics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ionpath and RareCyte, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ionpath, https://bouncewatch.com/company/ionpath, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes